These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1720273

  • 1. [Chemotherapy of prostatic cancer].
    Hirao Y, Kubota K, Yoshie T, Tabata S, Samma S, Ozono S, Okajima E, Sasaki K, Yoshikawa M, Tsumatani K.
    Hinyokika Kiyo; 1991 Aug; 37(8):817-24. PubMed ID: 1720273
    [Abstract] [Full Text] [Related]

  • 2. [Treatment for hormone-refractory or relapsing prostatic cancer].
    Hirao Y, Ozono S, Okajima E.
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
    [Abstract] [Full Text] [Related]

  • 3. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].
    Akimoto S, Akakura K, Masai M, Shimazaki J.
    Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216
    [Abstract] [Full Text] [Related]

  • 4. [Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy].
    Momose H, Arai K, Nakagawa Y, Fujimoto K, Tsujimoto S, Cho M, Tani Y, Saka M, Nakatsuji F, Iwai A.
    Hinyokika Kiyo; 1989 May; 35(5):781-8. PubMed ID: 2478001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of chemotherapy in urologic cancer].
    Miki T, Kuroda M, Kotake T.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1349-57. PubMed ID: 2471457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
    Hidaka T, Nakamura T, Shima T, Yuki H, Saito S.
    J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
    [Abstract] [Full Text] [Related]

  • 12. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M, Kotake T.
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM, Felip E, Rubio D, Vidal R, Bermejo B, Colomer R, Zanon V.
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.